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To identify preferentially expressed genes in the central endocrine organs of the hypo-
thalamus and pituitary gland, we generated transcriptome-wide mRNA proﬁles of the
hypothalamus, pituitary gland, and parietal cortex in male mice (12–15weeks old) using
serial analysis of gene expression (SAGE).Total counts of SAGE tags for the hypothalamus,
pituitary gland, and parietal cortex were 165824, 126688, and 161045 tags, respectively.
This represented 59244, 45151, and 55131 distinct tags, respectively. Comparison of these
mRNA proﬁles revealed that 22 mRNA species, including three potential novel transcripts,
were preferentially expressed in the hypothalamus. In addition to well-known hypothalamic
transcripts, such as hypocretin, several genes involved in hormone function, intracellu-
lar transduction, metabolism, protein transport, steroidogenesis, extracellular matrix, and
brain disease were identiﬁed as preferentially expressed hypothalamic transcripts. In the
pituitary gland, 106 mRNA species, including 60 potential novel transcripts, were preferen-
tially expressed. In addition to well-known pituitary genes, such as growth hormone and
thyroid stimulating hormone beta, a number of genes classiﬁed to function in transport,
amino acid metabolism, intracellular transduction, cell adhesion, disulﬁde bond formation,
stress response, transcription, protein synthesis, and turnover, cell differentiation, the cell
cycle, and in the cytoskeleton and extracellular matrix were also preferentially expressed.
In conclusion, the current study identiﬁed not only well-known hypothalamic and pitu-
itary transcripts but also a number of new candidates likely to be involved in endocrine
homeostatic systems regulated by the hypothalamus and pituitary gland.
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INTRODUCTION
Identiﬁcation of actively transcribed genes is fundamental to
understanding the function, molecular biology, and physiol-
ogy of speciﬁc tissues and organs. The serial analysis of gene
expression (SAGE) method and complementary DNA (cDNA)
Abbreviations: 3β-Hsd-1, 3β-hydroxysteroid dehydrogenase-1; ACTH, adrenocor-
ticotropic hormone;Anxa5, annexinA5;Ascl1, achaete–scute complex homolog-like
1 Drosophila; Cart, cocaine and amphetamine regulated transcript; CCD, com-
parative count display; cDNA, complementary DNA; Col1a2, procollagen, type
I alpha 2; Dlk1, delta-like 1 homolog Drosophila; Dmpk, dystrophia myotonica
kinase; DNA, deoxyribonucleic acid; EGF, epidermal growth factor; EST, expressed
sequence tag; FSH, follicle-stimulating hormone; GABA, gamma-aminobutyric
acid; Gat4, gamma-aminobutyric acid GABA-A transporter 4; Gh, growth hor-
mone;Grb10, growth factor receptor bound protein 10;Hap1, huntingtin-associated
protein 1; Hprt, hypoxanthine guanine phosphoribosyl transferase; Lh, luteiniz-
ing hormone; Mlc1, megalencephalic leukoencephalopathy with subcortical cysts
1 homolog human; NPY, neuropeptide Y; PCR, polymerase chain reaction; P4hb,
prolyl 4-hydroxylase beta polypeptide; Pitx1, paired-like homeodomain transcrip-
tion factor 1; Pnck, pregnancy upregulated non-ubiquitously expressed CaM kinase;
Pomc, proopiomelanocortin; SAGE, serial analysis of gene expression; Sat1, spermi-
dine/spermine N1-acetyltransferase; Six6, sine oculis-related homeobox 6 homolog
Drosophila; Sparc, secreted acidic cysteine rich glycoprotein; Spint2, serine protease
inhibitorKunitz type 2;Trh, thyrotropin releasing hormone;Tsh, thyroid stimulating
hormone.
microarray or gene chip analysis are efﬁcient strategies which
enable gene expression proﬁling at the transcriptome level. While
DNA microarray and gene chip strategies are limited by their
ability to analyze only previously known genes, SAGE does not
require a priori knowledge of the sequence of mRNA transcripts
expressed in the tissues of interest. Thus, SAGE can reveal unex-
pected but important changes in the expression of a number of
genes simultaneously. Moreover, SAGE allows the discovery of
potential novel transcripts that are differentially expressed. Indeed,
SAGE is a powerful method that can globally characterize gene
expression in tissues of interest and that can detect transcripts
differentially expressed under various physiological and diseases
conditions (Velculescu et al., 1995; St-Amand et al., 2001; Nishida
et al., 2006, 2009).
The hypothalamus and pituitary gland are key organs respon-
sible for the maintenance of homeostasis by controlling endocrine
systems and instinctive behaviors, such as feeding and drinking,
metabolism, reproduction, and the stress response. A previous
study using directional tag polymerase chain reaction (PCR) sub-
traction identiﬁed well-known hypothalamus-speciﬁc transcripts,
such as oxytocin, vasopressin, and proopiomelanocortin (Pomc),
as well as several novelmRNA species (Gautvik et al., 1996).A gene
expression proﬁling study using human samples also reported that
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speciﬁc genes, such as proteolipid protein, myelin basic protein,
carboxypeptidase E, and selenoprotein P were actively transcribed
in the hypothalamus (Hu et al., 2000). Additionally, there are sev-
eral reports on hypothalamic nuclei speciﬁc transcriptome using
laser capture microdissection coupled with microarray technol-
ogy (Segal et al., 2005; Tung et al., 2008; Paulsen et al., 2009;
Jovanovic et al., 2010). For instance, an earlier study identiﬁed top
12 preferentially expressed genes in ventromedial hypothalamic
nucleus relative to two adjacent hypothalamic nuclei (arcuate and
dorsomedial hypothalamus), such as steroidogenic factor 1 and
cytochrome P450CYP2J9 (Segal et al., 2005). Genes preferentially
expressed in the pituitary have also been identiﬁed by gene pro-
ﬁling studies (Hu et al., 2000; Tanaka et al., 2002). These include,
not only classical pituitary genes, such as growth hormone (Gh),
prolactin, and Pomc, but also novel candidates responsible for the
unique function of the pituitary gland (Hu et al., 2000; Tanaka
et al., 2002). However, it is likely that a large number of genes
that are essential for endocrine homeostatic systems of the central
endocrine regulatory organs remain to be identiﬁed.
To identify preferentially expressed transcripts in the hypothal-
amus and pituitary gland, we generated comprehensive mRNA
proﬁles using SAGE. In addition to the above mentioned strengths
of the SAGE method, this method has a very high reproducibility,
with r2 = 0.96 (Dinel et al., 2005). Moreover, no signiﬁcant dif-
ferences in expression levels were observed among mRNA species
estimated from twoSAGE libraries constructed from the samepool
of total RNA (Dinel et al., 2005). Thus, the current study provides
global characterization of the gene expression in the hypothalamus
and pituitary gland. Our study also identiﬁes genes with presently
unknown roles, including potential novel transcripts, which may
be involved in the key roles these organs essential for endocrine
homeostatic systems.
MATERIALS AND METHODS
RODENTS AND TISSUE SAMPLING
MaleC57BL/6mice (12–15weeks old)were obtained fromCharles
River Laboratories (St. Constant, QC, Canada). Female mice were
not used to avoid variability due to menstrual cycles. The male
micewere housed in an air-conditioned room(19–25˚C)with con-
trolled lighting from 07:15 to 19:15 h and were given free access to
laboratory chow (Lab Rodent Diet No. 5002, Ren’s Feed and Sup-
pliers,ON,Canada) andwater. The hypothalamus,pituitary gland,
and parietal cortex of 51 mice were pooled and used for expres-
sion proﬁling. After vertebral cervical dislocation under isoﬂurane
anesthesia, the brain was removed from the skull and the three
brain regions (hypothalamus, pituitary gland, and parietal cor-
tex) were immediately dissected, snap-frozen in liquid nitrogen
and stored at −80˚C until further use. All mice were handled in
a facility approved by the Canadian Council on Animal Care in
accordance with their Guide for Care and Use of Experimental
Animals.
SAGE AND DATA ANALYSIS
Total RNA was isolated from tissues using an RNA extraction kit
(TRIzol Reagent, Invitrogen, ON, Canada). Approximately, 6μg
of mRNA was extracted with Oligotex mRNA Mini Kit (Qia-
gen, Mississauga, Canada). The SAGE method was performed
as previously described (Velculescu et al., 1995; St-Amand et al.,
2001). In brief, double strand DNA complementary to RNA
(cDNA) was synthesized from the mRNA using a biotinylated
(T)18 primer and a cDNA synthesis kit (Gibco BRL,ON,Canada).
The cDNA libraries were digested with the restriction enzyme
NlaIII, which recognizes the sequence CATG. The 3′-terminal
cDNA fragments were captured using streptavidin-coated mag-
netic beads (Dynal, Oslo, Norway). After ligation of two annealed
linker pairs to the NlaIII-compatible sticky ends, the cDNA frag-
ments were digested with the tagging enzyme BsmFI (site present
in linkers), thereby releasing cDNA fragments that possessed short
15 base pairs tags. The released tags were ligated to form long
concatemers of ditags separated by NlaIII sites. The concatemers
were cloned into the SphI site of pUC19. White colonies were
screened by PCR and agarose gel electrophoresis to select inserts
longer than 500 bp for automated sequencing. The sequence and
occurrence of each tag were analyzed by the SAGEana software
program, which is a new version of SAGEparser.pl1. Tags corre-
sponding to linker sequences were discarded and duplicate con-
catemers were counted only once. To identify the transcripts, the
sequences of 15 bp SAGE tags (the CATG NlaIII site plus the
adjacent 11 bp tags) were matched with public databases. Classi-
ﬁcation of transcripts was mainly based on the genome directory
(Adams et al., 1995) at the TIGR web site2 and at gene ontol-
ogy3. Gene names of preferentially expressed genes were used to
search for their functions in the websites and information from
previously published literatures were also used for the classiﬁ-
cation of transcripts. The SAGE tags which did not match any
sequence in the public databases were classiﬁed as potential novel
transcripts. SAGE method quantiﬁes the gene expression level
relatively to total mRNA population (Velculescu et al., 1995; St-
Amand et al., 2001; Dinel et al., 2005; Nishida et al., 2005a, 2006,
2009). Therefore, SAGE does not require housekeeping genes as
internal standard. Tag number normalized by 100,000 is shown in
Tables.
Serial analysis of gene expression data are available at GEO4
under accession nos.: GSM38889, GSM38891, and GSM38893,
which correspond to the raw SAGE data of the male mouse
hypothalamus, pituitary gland, and parietal cortex, respectively.
QUANTITATIVE REAL-TIME PCR
For the conﬁrmation of SAGE results, the expression levels of
six mRNAs of interest [three mRNAs for preferentially expressed
genes in the hypothalamus (growth factor receptor bound pro-
tein 10, pregnancy upregulated non-ubiquitously expressed CaM
kinase, and huntingtin-associated protein 1) and three mRNAs for
preferentially expressed genes in the pituitary gland (RAB25mem-
ber RAS oncogene family, guanine nucleotide binding protein beta
3, and serine protease inhibitor Kunitz type 2)] were measured in
four male C57BL/6 mice (12–15weeks old) using Quantitative
real-time PCR (Q_RT-PCR). Brain regions (hypothalamus, pitu-
itary gland, and parietal cortex) were harvested as described above,
1ftp://ftp.pbrc.edu/public/eesnyder/SAGE/
2http://www.tigr.org/
3http://www.geneontology.org/
4http://www.ncbi.nlm.nih.gov/geo/
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preserved in RNAlater solution (Applied Biosystems, CA, USA),
and stored at −80˚C until RNA extraction and Q_RT-PCR analy-
sis. Total RNA was isolated from tissues using the RNAqueous®-
Micro Kit (Applied Biosystems, CA, USA). First-strand cDNA
was synthesized using isolated RNA with High Capacity RNA-to-
cDNAkit (AppliedBiosystems,CA,USA). The cDNAwas analyzed
in a Real-Time PCR System (StepOnePlus™, Applied Biosystems,
CA, USA) with speciﬁc Taq Man probes and PCR master mix
(TaqMan® Gene Expression Assays and TaqMan® Gene Expres-
sion Master Mix, Applied Biosystems, CA, USA). The relative
abundance of mRNAs was calculated by the comparative cycle
of threshold method with hypoxanthine guanine phosphoribosyl
transferase (Hprt ) mRNA as an internal standard. Hprt has stable
expression levels from embryonic life through adulthood in var-
ious tissues (Warrington et al., 2000). These measurements were
performed in triplicate and had <3% of coefﬁcient of variation.
The expression levels were expressed as fold changes (mean± SE)
to the parietal cortex values as control.
STATISTICAL ANALYSES
The comparative count display (CCD) program (Lash et al.,
2000) was used to identify the transcripts differentially expressed
between brain regions with more than a twofold change. The gene
expression levels were compared to detect preferentially expressed
transcripts, i.e., mRNA expressed at higher levels in a speciﬁc
region compared to the other two brain regions. For analyz-
ing Q_RT-PCR data, Mann–Whitney’s U test was performed.
For all tests, differences were considered statistically signiﬁcant
at p< 0.05.
RESULTS
Using SAGE, we have identiﬁed preferentially expressed tran-
scripts in the central endocrine organs of the hypothalamus and
pituitary gland. Total counts of SAGE tags from the hypothal-
amus, pituitary gland, and parietal cortex were 165824, 126688,
and 161045 tags, respectively. This represented 59244, 45151, and
55131 distinct tag species, respectively. Comparison of the three
transcriptomes revealed 22 and 106 transcripts expressed pref-
erentially in the hypothalamus and pituitary gland, respectively.
Among the 22 preferentially expressed transcripts in the hypothal-
amus, 13 were functionally classiﬁed as involved in cell signaling
and communication (Table 1) or other functions (Table 2). Of the
106 preferentially expressed transcripts in the pituitary gland, 40
were functionally classiﬁed as involved in components of hormone
pathways (Table 3), metabolism and cell signaling and communi-
cation (Table 4), cell and organism defense, and gene expression
(Table 5), and cell structure and division (Table 6). Both the hypo-
thalamus and pituitary gland have six preferentially expressed,
functionally unclassiﬁed transcripts (Table 7). In the hypothal-
amus and pituitary gland, 3 and 60 potentially novel transcripts,
respectively,were detected (Table 8). In addition,62 transcripts (29
functionally classiﬁed, 8 functionally unclassiﬁed, and 25 poten-
tial novel transcripts) were preferentially expressed in the parietal
cortex (Tables A1–A4 in Appendix).
PREFERENTIALLY EXPRESSED GENES IN THE HYPOTHALAMUS
Three well-known hypothalamic transcripts, cocaine and amphet-
amine regulated transcript (Cart ), hypocretin, and thyrotropin
releasing hormone (Trh), were preferentially expressed in the
Table 1 | Components of cell signaling and communication preferentially expressed in the hypothalamus.
Function and tag
sequences
Tag frequency Description (UniGene cluster, GenBank
accession no.)
Chromosomal
location
Parietal cortex Pituitary gland Hypothalamus
NEUROPEPTIDE (FEEDING BEHAVIOR)
TGTGACGCTGG 1 0 37 Cocaine and amphetamine regulated transcript
(Mm.75498, NM_013732)
13
GGCCGCCGCGC 1 0 33 Hypocretin (Mm.10096, NM_010410) 11
HORMONE
GAGACAAGGCC 1 0 39 Angiotensinogen (Mm.285467, NM_007428) 8
GTCAGATGAGG 0 0 8 Thyrotropin releasing hormone (Mm.1363, NM_009426) 6
INTRACELLULARTRANSDUCERS
TAACCGTTTTC 2 2 17 Growth factor receptor bound protein 10 (Mm.273117,
BC016111)
11
CATTGTGTGGC 5 1 39 Pregnancy upregulated non-ubiquitously expressed
CaM kinase (Mm.89564, NM_012040)
X
METABOLISM
TCTTGGGCTAA 6 2 31 Acetylcholinesterase (Mm.255464, NM_009599) 5
AGTTCCTTCGC 1 0 34 Calbindin 2 (Mm.2755, NM_007586) 8
TRANSPORT PROTEINS
GGGCTGGGTAG 4 2 36 Gamma-aminobutyric acid GABA-A transporter 4
(Mm.44683, NM_172890)
6
All tags are expressed at higher levels in the hypothalamus compared to other two regions, p<0.05.
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Table 2 | Other transcripts preferentially expressed in the hypothalamus.
Function and tag
sequences
Tag frequency Description (UniGene cluster, GenBank
accession no.)
Chromosomal
location
Parietal cortex Pituitary gland Hypothalamus
STEROIDOGENESIS
GCTCTGGGAGT 0 1 16 3β-Hydroxysteroid dehydrogenase-1 (Mm.140811,
NM_008293)
3
EXTRACELLULAR MATRIX
GAACATTGCAC 14 13 228 Secreted acidic cysteine rich glycoprotein (Mm.291442,
BC004638)
11
GENES RELATEDTO BRAIN DISEASE
TCTGCCAGAAG 3 5 43 Huntingtin-associated protein 1 (Mm.281700,
NM_010404)
11
TAGGAGCAAAG 11 2 40 Megalencephalic leukoencephalopathy with subcortical
cysts 1 homolog human (Mm.32780, NM_133241)
15
All tags are expressed at higher levels in the hypothalamus compared to other two regions, p<0.05.
Table 3 | Hormones preferentially expressed in pituitary gland.
Tag sequences Tag frequency Description (UniGene cluster, GenBank accession no.) Chromosomal
location
Parietal cortex Hypothalamus Pituitary gland
AAGTGTCGCCG 0 4 14963 Growth hormone (Mm.343934, NM_008117) 11
AAGTGTTGCCG 0 0 28 EST growth hormone (Mm.343934, AVI 73676)
CGCAGCGACGA 0 0 218 EST growth hormone (Mm.343934, BB749308)
AAAGTGTCGCC 0 0 40 EST growth hormone (Mm.343934, CB236481)
GCACCACGGGC 0 0 12 Growth hormone releasing hormone receptor
(Mm.89928, XM_132546)
6
CTGTGTGGCCA 2 2 347 Glycoprotein hormones, alpha subunit (Mm.l361,
NM_009889)
4
GTCCGAGTACT 0 0 75 Luteinizing hormone beta (Mm.5706l, NM_008497) 7
CTTGGGTGCAA 0 0 1307 Prolactin (Mm.1270, NM_011164) 13
CACTGAAAACT 0 0 107 EST prolactin (Mm.1270, BB025395)
AACAGCCAGGG 0 0 23 EST prolactin (Mm.1270, CB231671)
GGCGAGCTGAT 0 0 1496 Proopiomelanocortin-alpha (Mm.153634, BC061215) 12
GAGCACTTCCG 0 0 21 Proopiomelanocortin-alpha (Mm.277996, M30489)
TTACTCCTTAT 0 0 49 Thyroid stimulating hormone, beta subunit (Mm.110730,
NM_009432)
3
All tags are expressed at higher levels in the pituitary gland compared to other two regions, p<0.05.
hypothalamus (Table 1). Genes involved in hormone path-
ways (angiotensinogen), intracellular transduction [growth factor
receptor bound protein 10 (Grb10) and pregnancy upregulated
non-ubiquitously expressed CaM kinase (Pnck)], metabolism
(acetylcholinesterase and calbindin 2), and protein transporta-
tion [gamma-aminobutyric acid GABA-A transporter 4 (Gat4)]
were also preferentially expressed.Other hypothalamic genes iden-
tiﬁed were genes involved in steroidogenesis [3β-hydroxysteroid
dehydrogenase-1 (3β-Hsd-1)], the extracellular matrix [secreted
acidic cysteine rich glycoprotein (Sparc)], and mRNAs related
to brain disease [huntingtin-associated protein 1 (Hap1) and
megalencephalic leukoencephalopathy with subcortical cysts 1
homolog human (Mlc1); Table 2].
PREFERENTIALLY EXPRESSED GENES IN THE PITUITARY GLAND
A number of well-known pituitary genes, such as Gh, GH releas-
ing hormone receptor, glycoprotein hormones alpha subunit,
luteinizing hormone (Lh) beta, prolactin, proopiomelanocortin
(Pomc), and thyroid stimulating hormone (Tsh) beta subunit were
preferentially expressed in the pituitary gland (Table 3). Genes
involved in transport [annexin A5 (Anxa5), chromogranin B,
members of the RAS oncogene family, RAB4B and RAB25], amino
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Table 4 | Components of the metabolism and cell signaling/communication preferentially expressed in pituitary gland.
Function and tag
sequences
Tag frequency Description (UniGene cluster, GenBank
accession no.)
Chromosomal
location
Parietal cortex Hypothalamus Pituitary gland
TRANSPORT
AAGGGTGCTGG 6 7 39 Annexin A5 (Mm.1620, NM_009673) 3
TGACTAGCGTG 2 0 48 Chromogranin B (Mm.255241, NM_007694) 2
CAGCCGGCTAT 4 1 53 Chromogranin B (Mm.255241, AK019893)
GCTGTGGCCCT 1 1 9 RAB4B, member RAS oncogene family (Mm.197516,
NM_019394)
7
TGATCTGCCCA 0 0 10 RAB25, member RAS oncogene family (Mm.26994,
NM_016899)
3
AMINOACID METABOLISM
AAGTGTCGCTG 0 0 41 Mus musculus similar to spermidine/spermine
Nl-acetyltransferase (LOC231081; Mm.319224,
XM_131957)
X
INTRACELLULARTRANSDUCERS
ATAATGAATAA 0 0 17 Delta- like 1 homolog Drosophila (Mm.157069,
NM_010052)
12
AGCCCCCTATT 0 1 12 EST dystrophia myotonica kinase, B15 (Mm.6529,
BC056615)
7
ACTATGGATGT 0 0 15 Guanine nucleotide binding protein, beta 3 (Mm.68889,
NM_013530)
6
CAGGGCCTCAC 0 0 21 Tumor-associated calcium signal transducer 1 (Mm.4259,
BC005618)
17
TGCATAATTAA 0 0 12 Tumor-associated calcium signal transducer 1 (Mm.4259,
XM_147278)
CELL ADHESION
TGACTCCTTGC 3 4 29 CD164 antigen (Mm.269815, NM_016898) 10
All tags are expressed at higher levels in the pituitary gland compared to other two regions, p<0.05.
acid metabolism [Mus musculus similar to spermidine/spermine
N1-acetyltransferase (Sat1)], intracellular transducers [delta-
like 1 homolog Drosophila (Dlk1), dystrophia myotonica kinase
(Dmpk), guanine nucleotide binding protein beta 3 (Gnb3), and
tumor-associated calcium signal transducer 1], and cell adhe-
sion (CD164 antigen) were also preferentially expressed in this
organ (Table 4). Other pituitary genes identiﬁed were poten-
tially involved in disulﬁde bond formation [glucose-regulated pro-
tein (Grp58) and prolyl 4-hydroxylase beta polypeptide (P4hb)],
stress response (heat shock 70 kD protein 5 glucose-regulated
protein), transcription [achaete–scute complex homolog-like 1
Drosophila (Ascl1), paired-like homeodomain transcription factor
1 (Pitx1), and sine oculis-related homeobox 6 homologDrosophila
(Six6)], protein synthesis and turnover [proteasome (prosome,
macropain) subunit beta type 8 (large multifunctional protease
7), ribosomal protein S27a, and serine protease inhibitor Kunitz
type 2 (Spint2)] and cell differentiation (claudin 9 and neu-
ronatin; Table 5). Moreover, three transcripts involved in the
cytoskeleton (keratin complex 1 acidic gene 18), the extracellu-
lar matrix [procollagen type I alpha 2 (Col1a2)], and cell cycle
(cyclin D2) were identiﬁed as preferentially expressed pituitary
genes (Table 6).
CONFIRMATION OF SAGE RESULTS WITH Q_RT-PCR
As shown in Figure 1, the preferential expression of three genes in
the hypothalamus (A, B, C) and three genes in the pituitary gland
(D, E, F) detected by SAGE were conﬁrmed by Q_RT-PCR.
DISCUSSION
The 13 preferentially expressed mRNAs in the hypothalamus
included neuropeptides, hormones, intracellular transducers and
genes involved in metabolism, steroidogenesis, the extracellu-
lar matrix, and brain disease (Tables 1 and 2). Among the 13
transcripts, 4 are well-known hypothalamic neuropeptides or hor-
mones (Cart, hypocretin, angiotensinogen, andTrh). For instance,
hypocretin and Cart are key hypothalamic genes involved in the
regulation of feeding behavior. Hypocretin is known as an orexi-
genic gene, while Cart is an anorexigenic gene (Kristensen et al.,
1998; Sakurai, 2003). Hypocretin has other functions than the reg-
ulation of food intake; it regulates sleep and awake states and the
hypocretin knockout mouse is a model of human narcolepsy, a
hypersomnia disorder (Chemelli et al., 1999).
The preferentially expressed hypothalamic transcripts involved
in intracellular transduction were Grb10 and Pnck. GRB10 is a
member of a superfamily of adaptor proteins. In mouse, the Grb10
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Table 5 | Components of the cell and organism defense, and gene expression preferentially expressed in pituitary gland.
Function and tag
sequences
Tag frequency Description (UniGene cluster, GenBank
accession no.)
Chromosomal
location
Parietal cortex Hypothalamus Pituitary gland
DISULFIDE BONDS FORMATION
CAGGAGGAGTT 13 21 62 Glucose-regulated protein (Mm.263177, NM_007952) 2
GCCTGTGGCCT 7 11 48 Prolyl 4-hydroxylase, beta polypeptide (Mm.16660,
XM_126743)
11
STRESS RESPONSE
ACAAAACTGAT 6 7 28 EST heat shock 70 kD protein 5 glucose-regulated
protein (Mm.330160, CB233866)
2
TRANSCRIPTION FACTORS
TAATGAGATTA 1 1 11 Achaete–scute complex homolog-like 1 Drosophila
(Mm.76039, BC055748)
10
TCGCCGGGCGC 0 0 8 Paired-like homeodomain transcription factor 1
(Mm.135195, BC012696)
13
ATAGGTTTCTC 0 0 13 Sine oculis-related homeobox 6 homolog Drosophila
(Mm.57138, AF050130)
12
PROTEIN SYNTHESIS ANDTURNOVER
AAGGAAGACGG 0 0 8 Proteosome (prosome, macropain) subunit, beta type
8 (large multifunctional protease 7; Mm.180191,
NM_010724)
17
GGAAGCCACTT 28 25 78 Ribosomal protein S27a (Mm.l80003, NM_024277) 9
GTTCTGATCCT 2 7 28 Serine protease inhibitor, Kunitz type 2 (Mm.295230,
NM_011464)
7
CELL DIFFERENTIATION
CGCCTGCGAAG 0 0 9 Claudin 9 (Mm.103738, BC058186) 17
GGGGGAGTGGA 22 203 848 Neuronatin (Mm.233903, NM_010923) 2
All tags are expressed at higher levels in the pituitary gland compared to other two regions, p<0.05.
Table 6 | Components of cell structure and division preferentially in the pituitary.
Function and tag
sequences
Tag frequency Description (UniGene cluster, GenBank accession no.) Chromosomal
location
Parietal cortex Hypothalamus Pituitary gland
CYTOSKELETAL
CAAACTGTGCA 1 1 12 Keratin complex 1, acidic, gene 18 (Mm.22479, NM_010664) 15
EXTRACELLULAR MATRIX
CGCCTGCTAGC 1 1 21 Procollagen, type I, alpha 2 (Mm.277792, NM_007743) 6
CELL CYCLE
ACCAAAACGCA 2 2 15 Cyclin D2 (Mm.333406, NM_009829) 6
TACCCGCCGTC 1 1 18 EST Cyclin D2 (Mm.333406, BQ445605)
All tags are expressed at higher levels in the pituitary gland compared to other two regions, p<0.05.
gene is expressed from the maternal allele in almost all organs;
however, in the brain this gene shows biallelic expression (Hitchins
et al., 2002). GRB10 binds to the tyrosine-phosphorylated insulin
receptor via its Src homology 2 domain and inhibits signal trans-
duction (Langlais et al., 2004). GRB10 is known as a potential
regulator of GH signaling in hepatoma cells (Moutoussamy et al.,
1998), while in brain GRB10 is involved in neuronal insulin
signaling and energy metabolism (Lim et al., 2004). Another tran-
script involved in intracellular transduction was Pnck. Ca2+ is
an important intracellular second-messenger in signal transduc-
tion pathways. Many of the effects of Ca2+ are mediated through
its interaction with the Ca2+-binding protein, calmodulin. The
Ca2+/calmodulin complex activates calmodulin-dependent pro-
tein kinases, which ultimately regulate cellular processes, such as
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Table 7 | Unclassified transcripts preferentially expressed in the hypothalamus and pituitary gland.
Tag sequences Tag frequency Description (UniGene cluster, GenBank
accession no.)
Chromosomal
location
Hypothalamus Pituitary gland Parietal cortex
HYPOTHALAMUS
ACCCTGCTGTG 55 9 13 Abelson helper integration site (Mm.253280, NM_026203) 10
GAGAACTGGTT 59 10 19 Dispatched homolog 2 Drosophila (Mm.221499, NM_170593) 2
AAGAACAGGAG 23 2 2 Hypothetical protein 9430073I07 (Mm.l33187, NM_173016) 8
ACAGCAGTGTC 45 8 0 RIKEN cDNA 0610007P22 gene (Mm.328857, BC022659) 17
TGTATCCAGTG 133 17 35 RIKEN cDNA 1110020M21 gene (Mm.191892, NM_021432) 6
GCTGACTCTTG 31 1 2 RIKEN cDNA 2700055K07 gene (Mm.29358, NM_026481) 8
PITUITARY GLAND
TTTCTTTGTTA 0 8 0 cDNA sequence BC031468 (Mm.23713, NM_194055) 4
TGCTGAGATCA 2 15 2 EST GTL2, imprinted maternally expressed untranslated
mRNA (Mm.289645, BM123457)
12
GTGCTTTCAAT 1 31 2 EST GTL2, imprinted maternally expressed untranslated
mRNA (Mm.289645, Y13832)
12
CTCCTCCACTC 0 9 0 Expressed sequence AI987662 (Mm.206911, NM_178899) 6
TGAGAGGTGCC 2 36 1 RIKEN cDNA 5330417C22 gene (Mm.316890, BC022655) 3
GATGGATGGTG 0 15 0 RIKEN cDNA 5330437I02 gene (Mm.183576, NM_177028) 18
Tags are expressed at higher levels in each brain region compared to other two regions, p<0.05.
neurotransmitter release,metabolism,andgene expression (Schul-
man, 1993; Gardner et al., 2000). Pnck mRNA is expressed in a
tissue-speciﬁc manner in adult mice with the highest levels of
expression in the sex organs, the uterus, ovary, and testis, and in
the brain (Gardner et al., 2000). Since the current study showed
that Pnck mRNA is preferentially expressed in the hypothalamus,
the expression of this gene might be important not only in the
peripheral reproductive organs but also in the central hypothal-
amus, which regulates the secretion of sex hormones from the
uterus, ovary, and testis.
The hypothalamus is a central brain region of the auto-
nomic nervous system that uses acetylcholine as a neurotrans-
mitter. Acetylcholinesterase inhibits the actions of acetylcholine
by degrading acetylcholine into acetate and choline. The pref-
erential expression of acetylcholinesterase is consistent with a
previous report showing neuronal acetylcholinesterase staining in
the human hypothalamus (Darvesh and Hopkins, 2003). Acetyl-
cholinesterase gene expression can be critical for controlling the
activity of sympathetic and parasympathetic nervous systems; the
preferential expression of acetylcholinesterase is a molecular fea-
ture of the hypothalamus,which plays an important role as a brain
center of the autonomic nervous system. Another transcript clas-
siﬁed under metabolism is calbindin 2 (or calretinin). Calbindin
2 has Ca2+ buffering action against cytotoxicity of Ca2+ overload
in brain neurons (Persechini et al., 1989). Calbindin 2 is present in
oxytocin nerve terminals in the posterior pituitary,whose cell bod-
ies are located in the hypothalamus, and dehydration induced by
drinking 2%NaCl and deprivation of drinkingwater increased the
level of calbindin 2 protein in the posterior pituitary (Miyata et al.,
2000). Thus, the current data support the view that calbindin 2 is a
key hypothalamic molecule involved in the regulation of drinking
behavior.
GAT4 is a transporter of gamma-aminobutyric acid (GABA),
one of the major inhibitory neurotransmitters in the central ner-
vous system. There are four GABA transporters, GAT1–4 (Nelson,
1998). Gat2 and Gat3 are expressed in non-neural organs, such
as liver and kidney, whereas Gat4 and GAT1 are expressed in the
brain (Nelson, 1998). They play a role in the regulation of GABA
concentration in the synapse, and in its duration of action by
removing GABA from the synaptic cleft (Iverson, 1975). The pref-
erential expression of Gat4 in the hypothalamus is in agreement
with a previous study using in situ hybridization which showed
that Gat4 mRNA was observed in several brain regions, includ-
ing the hypothalamus, but not the cortex (Durkin et al., 1995). In
hypothalamic neurons, neuropeptide Y (NPY) and POMC exert
opposing actions on energy balance with NPY increasing food
intake. Subpopulations of NPY neuron terminals contain GABA
and synapse onto POMC neurons (Cowley et al., 2001). In addi-
tion, POMC neurons also release GABA (Hentges et al., 2004).
The preferential expression of Gat4 in the hypothalamus may
suggest an important role for Gat4 in the regulation of GABA
concentration in the hypothalamus.
Transcripts involved in steroidogenesis (3β-Hsd-1) and in the
extracellular matrix (Sparc) are also preferentially expressed in the
hypothalamus. It has been reported that the brain is a steroido-
genic organ that expresses the key steroidogenic enzyme,3β-Hsd-1
(Weidenfeld et al., 1980; Zwain and Yen, 1999). 3β-Hsd-1 converts
pregnenolone to progesterone, which is an important hormone
for the normal reproductive behavior in both sexes (Olster and
Blaustein, 1988). Thus, preferential expression of 3β-Hsd-1 in
the hypothalamus may suggest an involvement of this gene in
the regulation of sexual behavior by locally producing proges-
terone. Sparc was also preferentially expressed in the hypothal-
amus. We previously showed that Sparc mRNA is one of the
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Table 8 | Potential novel transcripts in the hypothalamus and pituitary
gland.
Tag sequences Tag frequency
Hypothalamus Pituitary gland Parietal cortex
HYPOTHALAMUS
GAAAATGAGAA 80 13 18
ATTTTCAGTTT 26 4 2
TGGGTTCTGAC 10 0 1
PITUITARY GLAND
GCGGGAAAAGC 1 1383 0
AAGTGTCGCCC 0 646 0
AAGTGTCGCCT 0 601 0
TTGGCGTCAAA 0 436 0
AAGTGTCGCCA 0 408 0
TCGGTTCTCTG 0 329 0
ACGTACTTCCG 1 222 0
GCTGGGGCCCG 0 194 0
TATGAAGAGAA 33 156 7
ACCCGCAGGTA 0 114 0
CCCTTGTCCAG 0 77 0
GAGTGTCGCCG 0 62 0
CAGGGAGGGGG 0 53 0
GAGTAGGAGCG 1 53 0
GTGAAGAAACC 7 50 9
AGGTGTCGCCG 0 42 0
AAGCGTCGCCG 0 40 0
ACCTCCGAGAA 0 39 0
AAGCCACCGTA 0 37 0
AAGTGCCGCCG 0 36 0
TCTGGACGGTC 7 36 1
TGTGCTGGCTT 1 34 0
ACCAGAATGAC 0 30 0
GTGACCACGGG 5 28 7
CAACCCCATTC 2 28 2
GCGGGAAAAGG 0 26 0
CTGACACAGCC 0 25 0
AAGTGACGCCG 0 24 0
AAGAGTCGCCG 0 23 0
GCGGGAAAAGT 0 21 0
GTAGGATCTTG 4 21 1
AAGTGTCACCG 0 21 0
GGAAGCTTTCA 0 21 0
TGGCCTCCGAG 0 19 0
AAGTGTCTCCG 0 17 0
GCATTAGCATT 1 16 1
GAATTCAATGA 0 16 0
AAGTGTCCCCG 0 16 0
AAATGTCGCCG 0 15 0
GTCACAGAGCT 1 15 1
ATGTGTCGCCG 0 14 0
GAATTGCTTCG 0 14 0
CTTGGGTGCGA 0 13 0
AAGTATCGCCG 0 13 0
(Continued)
Table 8 | Continued
Tag sequences Tag frequency
Hypothalamus Pituitary gland Parietal cortex
ACTGGATGAGC 0 13 1
TGCTTGAGTTT 1 12 0
GGTCACTTCCG 0 12 0
CAAATCAGGCT 0 11 1
GCGGGAAAAGA 0 10 0
ACGTACTTCCC 0 10 0
ACGTACTTCCT 0 10 0
TGGCTAAGAGT 0 10 0
AAGTGTGGCCA 0 10 0
AAGTGTCGTCG 0 10 0
GTGCCCCGGCC 1 10 0
AAGACCATAGC 0 9 0
GAAGTGTCGCC 0 9 0
TTCCTGCATAT 0 8 0
TAGTGTCGCCG 0 8 0
GGCGAGCAGAA 0 8 0
Tags are expressed at higher levels in each brain region compared to other two
regions, p<0.05.
most abundant transcripts in the hypothalamus (Nishida et al.,
2005b). Interestingly, Sparc-null mice have greater deposits of
subcutaneous fat, larger epididymal fat pads and elevated levels
of serum leptin compared to wild-type counterparts (Bradshaw
et al., 2003). On the other hand, Sparc mRNA levels in adi-
pose tissue have also been reported to be markedly increased
(three- to sixfold) in three different rodent models of obesity
(Tartare-Deckert et al., 2001). Physiological roles of the prefer-
entially expressed Sparc gene in the hypothalamus remain to be
determined.
Two transcripts related to brain disease (Hap1 and Mlc1) were
preferentially expressed in the hypothalamus. Huntington’s dis-
ease is an inherited autosomal dominant disorder,with progressive
dementia and abnormal movements that usually take the form of
choreic, rapid dance-like movements, typically of the hands and
neck. Huntington’s disease is caused by trinucleotide expansions
of the glutamine encoding CAG triplet in the huntingtin gene. The
polyglutamine expansion causes huntingtin to interact abnormally
with a number of proteins. HAP1 was found as a protein which
binds to huntingtin in proportion to the number of glutamines
present in the glutamine repeat region (Li et al., 1995). Interest-
ingly, mice lacking Hap1 showed neurodegeneration in the hypo-
thalamic region and decreased feeding behavior and loss of body
weight (Li et al., 2003). Another transcript classiﬁed as involved
in brain disease is Mlc1. The human Mlc1 gene and its murine
homolog encode a putative transmembrane protein expressed pri-
marily in brain. Mlc1 is highly expressed in the olfactory bulb
and cerebellum (Schmitt et al., 2003). Recessive mutations within
this gene cause megalencephalic leukoencephalopathy with sub-
cortical cysts, whose diagnostic features are motor disability in
the form of spasticity and ataxia, occasional seizures, mild cog-
nitive decline with slow progression (Singhal et al., 2003). The
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FIGURE 1 | Confirmation of preferentially expressed genes in the hypothalamus (A–C) and pituitary gland (D–F).The expression levels are normalized to
Hprt and are shown as fold difference compared with the parietal cortex. *Represents a signiﬁcant difference compared to the parietal cortex (p<0.05). Data
are represented as mean±SE.
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precise physiological role of Mlc1 in the hypothalamus remains to
be clariﬁed.
The pituitary gland is characterized by preferential expression
of genes related to hormones, such as Gh, GH releasing hor-
mone receptor, prolactin, Tsh beta subunit, Lh beta, glycoprotein
hormone alpha subunit, and Pomc (Table 3). The detection of
preferential expression of well-known pituitary and hypothalamic
markers validates our application of the SAGE technique.
Many mRNA transcripts involved in metabolism and cell sig-
naling/communication are preferentially expressed in the pituitary
(Table 4). Our results showing the preferential expression of
chromogranin B is in agreement with a previous report which
used human pituitary gland (Tanaka et al., 2002). Another tran-
script, Anxa5 is classiﬁed as a transporter that stimulates Lh beta
mRNA expression and secretion of LH and follicle-stimulating
hormone (FSH; Kawaminami et al., 2002). In addition, in the cur-
rent study, RAB4B and RAB25 were preferentially expressed in
the pituitary. RAB proteins are low molecular weight GTPases
that are master regulators of vesicle transport. Vesicle trans-
port is an essential process for secretion, since newly synthe-
sized secretory proteins are translocated into the endoplasmic
reticulum and are then transported to the membrane via the
Golgi apparatus by vesicles (Takai et al., 2001). Among the
RAB proteins, RAB27B is associated with secretory granules and
granuphilin, an effector protein of RAB27A, in a corticotroph
cell line, and over-expression of inactive RAB27B mutants sig-
niﬁcantly inhibits adrenocorticotropic hormone (ACTH) secre-
tion in these cells (Zhao et al., 2002). The current results
suggest that RAB25 and RAB4B mRNAs are new candidates
for important roles in the secretory pathway in the pituitary
gland.
Spermine, spermidine, and putrescine are representative
polyamines, which are abundantly present in endocrine organs,
such as the prostate and pancreas, as well as in carcinomas.
The polyamines function in cell proliferation and growth. The
current study showed that M. musculus similar to Sat1 was
preferentially expressed in the pituitary. This is a rate-limiting
enzyme which catalyzes the N1 acetylation of spermidine and
spermine, and converts them to putrescine. Female transgenic
mice over-expressing Sat1 are infertile (Pietila et al., 1997).
Because the reproductive function of the ovary is regulated
by gonadotropin hormones, which are synthesized in the pitu-
itary gland, the current result suggests potential importance
of Sat1 expression in the regulation of pituitary gonadotropin
hormones.
Heterotrimeric guanine nucleotide binding proteins, known
as G proteins, play a key role in signal transduction from seven-
transmembrane receptors to intracellular effectors. They are het-
erodimers composed of three distinct subunits, alpha, beta, and
gamma (Lania et al., 2001). Among these subunits, the cur-
rent study revealed that Gnb3 was preferentially expressed in
the pituitary. Previous studies have reported that defects in G
protein-coupled signal transduction cause endocrine disorders
(Lania et al., 2001). Previous and current data, therefore, sug-
gest that this molecule may play an important role in normal
endocrine regulation, by its preferential expression in the pituitary
gland.
Dlk1 is an epidermal growth factor (EGF)-like protein, syn-
thesized as a transmembrane protein with six tandem EGF like
repeats. Dlk1 expression is restricted to endocrine organs, such
as the adrenal gland and placenta (Laborda et al., 1993). The
preferential expression of Dlk1 in the pituitary is in agreement
with the expression of this gene being restricted to endocrine
organs. Myotonic dystrophy, which shows a progressive decrease
inmusclemass, is an autosomal dominant disorder caused byCTG
repeat expansion in the Dmpk gene. Patients with myotonic dys-
trophy present hypogonadism and higher basal levels of ACTH
and corticosteroid (Brisson et al., 2002). The current result of
preferential expression of Dmpk in the pituitary supports the idea
that this gene plays an important role in gonadotropin and ACTH
secretion.
The current study also revealed two pituitary genes
(three mRNAs) classiﬁed under metabolism and cell signal-
ing/communication (tumor-associated calcium signal transducer
1 and CD164 antigen). Tumor-associated calcium signal trans-
ducer 1 (Epithelial cell adhesion molecule) was ﬁrst identiﬁed
as a tumor-speciﬁc antigen on several carcinomas. CD164, is
expressed in hematopoietic cells in bone marrow and plays a
role in hematopoiesis (Zannettino et al., 1998). CD164 protein
contains 178 amino acids and is extremely rich in serine and
threonine (Zannettino et al., 1998). Thus, these molecules with
presently unknown functions in the pituitary are promising targets
for future studies of cell signaling in the pituitary gland.
We detected three preferentially expressed transcription fac-
tors in the pituitary (Table 5). PITX1 was previously charac-
terized as a mouse transcription factor on the basis of its abil-
ity to activate pituitary transcription of the Pomc gene (Lam-
onerie et al., 1996). Six6 is strongly expressed in the developing
pituitary gland (Lopez-Rios et al., 1999) and Ascl1 is a basic
helix-loop-helix transcription factor and acts as a developmental
regulator in the mammalian central nervous system (Guillemot
et al., 1993). In addition, there are two preferentially expressed
transcripts involved in cell differentiation. Neuronatin is selec-
tively expressed in the developing brain (Joseph et al., 1994). In
adult humans, the anterior pituitary gland was the only place
where neuronatin was highly expressed among various tissues
(Usui et al., 1997). We previously reported that neuronatin is
one of the most abundant transcripts in the mouse pituitary
(Nishida et al., 2005b). Claudin 9 belongs to the claudin family
of tight junction transmembrane proteins, which is expressed in
the developing mouse submandibular gland (Hashizume et al.,
2004). The current results suggest that these genes have important
roles not only in the developing but also in the adult pituitary
gland.
We also identiﬁed three preferentially expressed genes involved
in protein degradation, ribosomal protein S27a, which encodes
ubiquitin, SPINT2, a proteasome (prosome, macropain) subunit,
and proteasome subunit beta type 8 (large multifunctional pro-
tease 7). Proteasome inhibitors induce apoptosis in GH- and
prolactin-secreting rat pituitary tumor cells (Yu et al., 2002). In
addition, exposure of pancreatic islets to cytosolic cysteine pro-
tease (calpain) inhibitors impairs mitochondrial fuel metabolism
and the exocytosis of insulin (Zhou et al., 2003). Northern blot
analysis showed that Spint2 mRNA was expressed in endocrine
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organs, such as pancreas, prostate, and testis (Kawaguchi et al.,
1997). Spint2 contains a putative N-terminal signal peptide
sequence, a hydrophobic membrane-associated C-terminal region
and a central region that encodes the cleaved protein, suggesting
that this protein could be produced as an active membrane-
associated protein that is proteolytically cleaved and secreted
(Kawaguchi et al., 1997). Furthermore, DNA arrays revealed that
Spint2 is expressed at signiﬁcantly lower levels in abnormal testis
in humans (Rockett et al., 2004). These previous results and the
preferential expression of these three genes in the pituitary sug-
gest important roles for genes related to protein synthesis and
degradation in the regulation of pituitary endocrine function.
P4HB is a ubiquitous, abundant protein that is located primar-
ily in the endoplasmic reticulum (Cheng et al., 1987). P4HB has
a protein disulﬁde isomerase activity (Koivu et al., 1987). Disul-
ﬁde bonds between and within polypeptides stabilize tertiary and
quaternary structures. GRP58 also has protein disulﬁde isomerase
activity. Since GH has two disulﬁde bonds and its mRNA is highly
abundant in the adult pituitary gland (Nishida et al., 2005b), it
is reasonable that genes involved in forming disulﬁde bonds are
preferentially expressed in the pituitary.
There are four preferentially expressed transcripts classiﬁed as
components of cell structure and cell division (Table 6). The pre-
cise function of these genes in the adult pituitary is unclear at
present. One of these genes is cyclin D2. This gene is known to
be extensively inactivated in various pituitary tumor cell lines by
increased DNA methylation (Qian et al., 2000). Ovaries of FSH-
deﬁcient mice demonstrate a modest decrease in cyclin D2 mRNA,
without up-regulation of cell cycle inhibitor mRNAs associated
with luteinization (Burns et al., 2001). Although components of
the FSH-null phenotype may be caused by partial cyclin D2 loss of
function, these ﬁndings indicate that themechanisms of granulosa
cell cycle arrest in FSH beta knockout mice are distinct from those
of cycle withdrawal at luteinization (Burns et al., 2001). The pref-
erential expression of cyclin D2 suggests that this molecule plays a
key role for normal cell cycling in the adult pituitary gland.
The present study has identiﬁed six unclassiﬁed and three
potential novel transcripts preferentially expressed in the hypo-
thalamus (Table 7).Moreover,6 unclassiﬁed and60potential novel
transcripts were detected to be preferentially expressed in the pitu-
itary (Table 8). These mRNAs potentially play important roles in
these central endocrine regions; therefore, full-length cloning and
further characterization of the potential novel transcripts should
be undertaken.
There is a limitation of the current study that should be
described. We used whole hypothalamus, which is a heteroge-
neous region of the brain. Since each of hypothalamic nuclei
occupies relatively a small portion of whole hypothalamus,mRNA
species concentrated in a speciﬁc nucleusmight be diluted by other
parts of the hypothalamus to an undetectable level. For instance,
hypothalamic neuropeptides POMC and NPY are localized in the
arcuate nucleus (Cowley et al., 2001). In the current study, we
could not detect tags corresponding to Pomc and Npy, proba-
bly because of their low abundance in the whole hypothalamus.
Additionally, orexigenic Npy is not expected to be abundantly
expressed in the hypothalamus of ad libitum fed mice used in the
present study. It is assumed that low abundance mRNA species
such as Pomc and Npy would be detected with greater number
of SAGE tags. Since a large amount of total RNA (100μg per
group) was required to generate each cDNA library in the current
SAGE study, we used 51 mice to obtain sufﬁcient amount of RNA
from the small brain regions, and to eliminate the individual vari-
ation. Thus, for the SAGE study it would be impractical to use
speciﬁc hypothalamic nuclei in mice, which is exceedingly small.
Other researchers have investigated transcriptome from individual
hypothalamic nuclei using laser capture microdissection coupled
with microarray technology (Segal et al., 2005; Tung et al., 2008;
Paulsen et al., 2009; Jovanovic et al., 2010). SAGE method can
precisely measure changes in the expression of previously well-
studied genes, as well as the less commonly studied, and even novel
transcripts. Additionally, although SAGE is time-consuming, this
method does not suffer from non-speciﬁc hybridization. Thus,
further effort to identify preferentially expressed genes in thehypo-
thalamic nuclei speciﬁc transcriptome using superior techniques
such as laser capture coupled with SAGE is warranted.
In conclusion, the current analysis of mRNA proﬁles identi-
ﬁed a number of genes with preferential expression in the central
endocrine organs of the hypothalamus and pituitary gland. In
addition to well-known genes, such as Cart and Trh, the current
study revealed that genes encoding Grb10, Pnck, Gat4, 3β-Hsd-1,
Hap1, and Mlc1 were preferentially expressed in the hypothala-
mus. In the pituitary gland, not only well-known pituitary genes,
such as Gh, but a number of other genes, such as Anxa5, Sat1,
Dlk1, CD164 antigen, Grp58, Ascl1, Spint2, claudin 9, and cyclin
D2 were also preferentially expressed in the pituitary. Moreover,
the current study showed a number of preferentially expressed,
uncharacterized transcripts, including potential novel transcripts
(3 in the hypothalamus and 60 in the pituitary). Therefore, the
current study characterized the global preferential gene expres-
sion in the central endocrine organs of the hypothalamus and
pituitary gland. In addition to the preferential expression of sev-
eral well-known hypothalamic and pituitary genes, the current
SAGE analysis identiﬁed a number of new candidates involved
in endocrine homeostatic systems regulated by the hypothalamus
and pituitary gland, such as feeding and drinking, metabolism,
reproduction, and the stress response.
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APPENDIX
Table A1 | Components of cell signaling preferentially expressed in the cortex.
Function and tag
sequences
Tag frequency Description (UniGene cluster, GenBank
accession no.)
Chromosomal
location
Hypothalamus Pituitary gland Parietal cortex
CALCIUMAND CALMODULIN SIGNALTRANSDUCTION
GCTTCCCCACC 8 0 82 Calcium/calmodulin-dependent protein 18
ACAAACTTAGG 68 32 171 Calmodulin 1 (Mm.285993, M 19381) 12
GTCCTGCAGGA 1 0 14 Inositol 1,4,5-trisphosphate 3-kinase A 2
CAGCTCTGCCT 29 0 363 Neurogranin (Mm.335065, AK002933) 9
TTACCATACTG 0 0 9 Neurogranin (Mm.335065, NM_022029)
AAGGACTGATT 2 2 30 Protein phosphatase 3, catalytic subunit, alpha isoform
(Mm.80565, XM_131226)
3
AGGTTTTGTTT 1 1 26 RAS guanyl releasing protein 1 (Mm.42150, BC057341) 2
CELL ADHESION
GCTGTGGGTCG 3 1 17 Intercellular adhesion molecule 5, telencephalin
(Mm.4629, NM_008319)
9
HORMONE
GGCTGGATGGA 8 0 122 Cholecystokinin (Mm.26l9, NM_031161) 9
RECEPTOR
GCTGCCCTGCC 1 1 14 EST cholinergic receptor, muscarinic 1, CNS
(Mm.240607, BY652206)
19
TRANSPORT
TAGCTGTAACG 24 41 111 ATPase, Na+/K+ transporting, alpha 1 polypeptide
(Mm.280l03, NM_144900)
3
AATTCGCGGAT 6 0 91 Transthyretin (Mm.2l08, BC024702) 18
All tags are expressed at higher levels in the parietal compared to other two regions, p<0.05.
Frontiers in Endocrinology | Genomic Endocrinology January 2012 | Volume 2 | Article 111 | 14
St-Amand et al. Gene expression in neuroendocrine organs
Table A2 | Components of metabolism, gene expression, and others preferentially expressed in the cortex.
Function and tag
sequences
Tag frequency Description (UniGene cluster, GenBank
accession no.)
Chromosomal
location
Hypothalamus Pituitary gland Parietal cortex
METABOLISM
Energy
ATAATACATAA 71 24 196 ATP6 (NC_001569:Pos:8596) Mitochondrial DNA
Lipid
GTCTGGGGGGA 4 5 32 Monoglyceride lipase (Mm.272197, BC057965) 6
TGAGCATCGGG 8 7 39 Monoglyceride lipase (Mm.272197, NM_011844)
TATTGCAAGGT 3 2 32 Oxysterol binding protein-like 1A (Mm.259470,
NM_020573)
18
Sugar and glycolysis
TGCTAAGTCCC 1 0 14 UDP-N -acetyl-alpha-d-galactosamine polypeptide
N -acetylgalactosaminyltransferase 9 (Mm.275748,
XM_132253)
5
TRANSCRIPTION FACTORS
TAAATAGACAA 2 2 18 Myocyte enhancer factor 2C (Mm.24001,
NM_025282)
13
AAGCTTGGATT 2 0 17 EST myocyte enhancer factor 2C (Mm.24001,
BE654834)
GAGCTATCTGG 1 0 16 Forkhead box Gl (Mm.4704, NM_008241) 12
DNA BINDING
AAGTGCAGTAC 8 2 30 Purine rich element binding protein B (Mm.296150,
AK009365)
11
CYTOSKELETAL
GTGCAGATAGT 11 3 43 Spectrin beta 3 (Mm.2ll852, XM_129130) 19
NEURITE GROWTH
AGGGGCCGGTT 7 1 48 Nenritin 1 (Mm.232930, NM_153529) 13
HOMEOSTASIS-GENERAL
TGGACGGTGGT 5 3 26 Carbonic anhydrase 11 (Mm.27736, NM_009800) 7
All tags are expressed at higher levels in the parietal cortex compared to other two organs, p<0.05.
Table A3 | Components of synapse preferentially expressed in the cortex.
Tag sequences Tag frequency Description (UniGene cluster, GenBank accession no.) Chromosomal
location
Hypothalamus Pituitary gland Parietal cortex
GTACTTGGCTG 1 2 24 Synaptic vesicle glycoprotein 2 b (Mm.273082, AK122359) 7
GGAACAGGAGG 2 0 25 Synaptopodin (Mm.252321, AK129267) 18
TATATTAAATC 1 0 11 Synaptosomal-associated protein 25 (Mm.45953,
XM_130450)
2
CTGTAATGATA 6 1 35 EST synaptosomal-associated protein 25 (Mm.45953,
AV330750)
CAGCGGGAGCT 16 4 57 Syntaxin 1A brain (Mm.6225, NM_016801) 5
All tags are expressed at higher levels in the parietal cortex compared to other two organs, p<0.05.
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Table A4 | Unclassified transcripts preferentially expressed in the parietal cortex.
Tag sequences Tag frequency Description (UniGene cluster, GenBank accession no.) Chromosomal
location
Hypothalamus Pituitary gland Parietal cortex
ATTCTCCCTGT 5 0 20 Expressed sequence N28178 (Mm.240965, AK122428) 4
CATTACTGCAG 1 0 16 EST expressed sequence BB075781 (Mm.230702,
W39846)
17
TTCTTTTCCCT 1 0 12 Formin-like (Mm.138913, AF215666) 11
CAGGGATCAAT 1 0 10 EST Mus musculus 10days neonate cortex cDNA, RIKEN
full-length enriched library, clone A830028E23 product
unknown EST, full insert sequence (Mm.192128,
AK043754)
6
ACTGGTGACTG 3 2 25 ProSAPiPl protein (Mm.40621, NM_197945) 2
GTATTTGCAAA 21 5 206 RIKEN cDNA 1810006K23 gene (Mm.41603, AK007352) 4
CTGTGTGGCCC 1 2 22 RIKEN cDNA E130012A19 gene (Mm.24506, NM_175332) 11
CGGTCTAGTCC 12 2 136 EST RIKEN cDNA 1810006K23 gene (Mm.41603,
BF323011)
4
POTENTIAL NOVELTRANSCRIPTS
AGGAACCAAAG 45 11 148
ACCGACAAGGC 12 8 76
GCGAGGAAGAA 1 1 76
TGTGCCCCAGG 14 5 75
TCACATCCAAG 9 2 63
CTCCCTGGGGG 8 0 52
TGATGGAAGGT 8 6 47
CAAAACAGGCA 5 2 42
TGGTCTTTTTG 10 3 37
CACAAAAGAAT 4 0 36
AAGGTGGATAC 2 1 29
GCTATTTGCCT 5 2 29
GTATCATTGGG 4 2 22
TGCTCTGGAGG 4 2 22
CTGGGCGCGTG 2 0 22
GGACGGCAGTT 1 0 20
TGACAAGACAC 4 1 20
GTCGCGTCCGG 4 2 19
GAGCCCCTTGG 2 1 18
TGGCCCCGGAA 1 0 18
TAGTGTTTTCC 2 0 14
GCTGGAACAGA 2 2 14
GACATCAGTTG 2 0 12
TAGGGCCCTAG 1 0 11
AAAACCTCCTC 1 0 9
Tags are expressed at higher levels in the parietal cortex region compared to other two regions, p<0.05.
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